Drug Shortage Report for TEVA-COTRIDIN EXPECTORANT

Last updated on 2020-11-27 History
Report ID 129053
Drug Identification Number 02053403
Brand name TEVA-COTRIDIN EXPECTORANT
Common or Proper name COTRIDIN EXPECTORANT SYRUP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TRIPROLIDINE HYDROCHLORIDE PSEUDOEPHEDRINE HYDROCHLORIDE GUAIFENESIN CODEINE PHOSPHATE
Strength(s) 2MG 30MG 100MG 10MG
Dosage form(s) SYRUP
Route of administration ORAL ORAL
Packaging size 500ml
ATC code R05FA
ATC description COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-25
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-11-27
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-11-27 French Compare
v1 2020-11-27 English Compare